MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.31
-0.05 (-0.68%)
Jun 18, 2026, 3:40 PM HKT

HKG:2235 Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, HKG:2235 stock has a consensus rating of "Buy" and an average price target of $11.92. The average 1-year stock price forecast is 63.06% higher than the current stock price, while the lowest is $8.99 (+22.98%) and the highest is $14.65 (+100.41%).

Price Target: $11.92 (+63.06%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$8.99$11.92$12.11$14.65
Change+22.98%+63.06%+65.66%+100.41%
* Price targets were last updated on Apr 29, 2026.

Analyst Ratings

The average analyst rating for HKG:2235 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJul '25Sep '25Jan '26Feb '26Mar '26Apr '26
Strong Buy111001
Buy000000
Hold000001
Sell000000
Strong Sell111110
Total222112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Citic Securities
No rating
Citic Securities
Buy
Maintains
$12.00
BuyMaintains$12.00+64.16%Apr 29, 2026
Goldman Sachs
Goldman Sachs
Hold
Upgrades
$8.90
HoldUpgrades$8.90+21.75%Apr 26, 2026
Unknown Analyst
Huachuang Securities
No rating
Huachuang Securities
Buy
Maintains
$14.00
BuyMaintains$14.00+91.52%Apr 16, 2026

Financial Forecast

Revenue This Year
884.98M
from 660.79M
Increased by 33.93%
Revenue Next Year
1.13B
from 884.98M
Increased by 27.81%
EPS This Year
0.19
from 0.07
Increased by 171.43%
EPS Next Year
0.41
from 0.19
Increased by 113.16%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
151.40M173.61M253.23M345.62M660.79M884.98M
Revenue Growth
101.13%14.67%45.86%36.48%91.19%33.93%
Gross Profit
70.88M79.69M117.14M179.08M348.31M484.97M
Gross Margin
46.82%45.91%46.26%51.81%52.71%54.80%
Operating Income
-60.17M-120.34M-195.29M-135.52M-891.14K61.65M
Net Income
-48.15M-35.04M-125.02M-63.12M40.15M84.96M
EPS
----0.070.19
EPS Growth
-----171.43%
Forward PE
----61.2733.23
Free Cash Flow
-50.98M-146.24M-126.24M-143.41M-32.80M38.64M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High906.0M
Avg885.0M
Low864.0M

Revenue Growth

Revenue Growth202620272028
High
37.1%
Avg
33.9%
Low
30.8%

EPS Forecast

EPS202620272028
High-
Avg0.19
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
171.4%
Low-